PRKCA and acute lymphoblastic leukemia: The identification of very high risk T-ALL patients within the MRD-HR stratum, discriminated by PKCα low expression, is of particular clinical relevance since no other prognostic factors are able to recognize this subgroup of patients characterized by an unfavourable outcome.